AI eye scan could predict who needs more shots for blinding disease
NCT ID NCT07402629
First seen Feb 21, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study aims to see if a special eye scan (OCTA) analyzed by artificial intelligence can predict how well patients with a vision-threatening condition called myopic choroidal neovascularization (mCNV) will respond to standard anti-VEGF injections. Researchers will follow 110 patients for two years, tracking vision changes and disease recurrence. The goal is to build a model that helps doctors personalize treatment plans and improve long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIC CHOROIDAL NEOVASCULARIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.